HIKAL
|
The Current P/B Ratio of HIKAL is 2.27.
| Share Price | ₹220.4 | May 27,2026 |
| Market Cap | ₹2,717.5 Cr | |
| Book Value | ₹1,198.8 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.27x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹2,717.5 Cr] as on May 27,2026
(/) Book Value [ ₹1,198.8 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.27x ]
Thus, for HIKAL , the investors are currently willing to pay '2.27 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.26x.
- HIKAL 's operated at median p/b ratio of 3.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2021 of 1.9x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| HIKAL | 1,198.80 | 2.27 | 2,717.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.30 | 442,677.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.77 | 180,458.0 |
| TORRENT PHARMACEUTICALS LTD | 8,389.23 | 18.32 | 153,685.0 |
| CIPLA LTD | 34,431.90 | 3.33 | 114,562.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.91 | 110,095.0 |
| MANKIND PHARMA LTD | 16,300.30 | 6.13 | 99,957.1 |
| LUPIN LTD | 22,448.30 | 4.64 | 104,097.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.03 | 109,272.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.18 | 82,604.1 |
| LAURUS LABS LTD | 5,300.06 | 14.07 | 74,562.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.18x |
| Max industry PB | 18.32x |
| Median industry PB | 4.64x |
| Average industry PB | 6.72x |
You may also like the below Video Courses